Could a diabetes drug sharpen your mind? new study explores semaglutide for depression-related brain fog
NCT ID NCT04466345
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 32 times
Summary
This study looked at whether semaglutide, a drug used for diabetes and weight loss, can help improve cognitive function in adults with major depressive disorder who are also overweight. 72 participants took either semaglutide or a placebo alongside their usual depression treatment. The goal was to see if the drug could boost executive function, memory, and concentration.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Toronto Western Hospital
Toronto, Ontario, M5T 2S8, Canada
Conditions
Explore the condition pages connected to this study.